KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) EPS (Basic) (2016 - 2025)

Quest Diagnostics (DGX) has disclosed EPS (Basic) for 17 consecutive years, with $2.21 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 11.62% to $2.21 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.87 through Dec 2025, up 14.01% year-over-year, with the annual reading at $8.87 for FY2025, 14.01% up from the prior year.
  • EPS (Basic) hit $2.21 in Q4 2025 for Quest Diagnostics, up from $2.18 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $5.05 in Q2 2021 to a low of $0.93 in Q4 2022.
  • Historically, EPS (Basic) has averaged $2.41 across 5 years, with a median of $2.06 in 2023.
  • Biggest five-year swings in EPS (Basic): surged 375.68% in 2021 and later tumbled 71.12% in 2022.
  • Year by year, EPS (Basic) stood at $3.22 in 2021, then crashed by 71.12% to $0.93 in 2022, then soared by 84.95% to $1.72 in 2023, then grew by 15.12% to $1.98 in 2024, then grew by 11.62% to $2.21 in 2025.
  • Business Quant data shows EPS (Basic) for DGX at $2.21 in Q4 2025, $2.18 in Q3 2025, and $2.51 in Q2 2025.